Pär Karlsson

Om mig
Publikationer
Populärvetenskap och samverkan

Om mig

Jag är en statistiker. Jag har som mål i livet att lära mig så mycket som
möjligt om statistik. Mitt främsta intresse är de grundläggande
filosofiska frågorna om hur man kan dra slutsatser om världen från våra
observationer.
Tidigare i livet så har jag arbetat på Astra och SCB. Där har
datamaterialen varit noggrant kontrollerade, men min utmaning här på KI
är att ta hand om registerdata, med alla dess brister.
Högskoleexamen på matematikerlinjen med inriktning statistik (1987)
Stockholms universitet

Artiklar

Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024;33(8):e5878
Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006-2019
Karlsson P; Gembert K; Esslinger S; Geldhof A; Gissler M; Leinonen MK; Otero-Lobato M; Pedersen L; Cesta CE
Article: PAEDIATRIC AND PERINATAL EPIDEMIOLOGY. 2024;38(6):521-531
Detection of major congenital malformations depends on length of follow-up in Swedish National Health Register Data: Implications for pharmacoepidemiological research on medication safety in pregnancy
Chacon SS; Karlsson P; Cesta CE
Article: JOURNAL OF SLEEP RESEARCH. 2024;:e14267
Trends in hypnotic drug use in depression 2007-2017: A Swedish population-based study
Nygren A; Brenner P; Brandt L; Karlsson P; Eloranta S; Reutfors J
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(3):531-539
Antibiotic use during pregnancy in Sweden: A nationwide utilization study covering 2007-2019
Nakitanda AO; Odsbu I; Pasternak B; Karlsson P; Pazzagli L
Article: BMC GASTROENTEROLOGY. 2024;24(1):21
Validation of diagnoses of liver disorders in users of systemic azole antifungal medication in Sweden
Giunta DH; Karlsson P; Younus M; Berglind IA; Kieler H; Reutfors J
Article: DRUG SAFETY. 2023;46(7):661-675
Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries
Dudukina E; Szepligeti SK; Karlsson P; Asomaning K; Daltveit AK; Hakkarainen K; Hoti F; Kieler H; Lunde A; Odsbu I; Rantanen M; Reutfors J; Saarelainen L; Ehrenstein V; Toft G
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;323:292-298
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia
Tiger M; Wesselhoeft R; Karlsson P; Handal M; Bliddal M; Cesta CE; Skurtveit S; Reutfors J
Article: JAMA PSYCHIATRY. 2023;80(2):156-166
Association of In Utero Antipsychotic Medication Exposure With Risk of Congenital Malformations in Nordic Countries and the US
Huybrechts KF; Straub L; Karlsson P; Pazzagli L; Furu K; Gissler M; Hernandez-Diaz S; Norgaard M; Zoega H; Bateman BT; Cesta CE; Cohen JM; Leinonen MK; Reutfors J; Selmer RM; Suarez EA; Ulrichsen SP; Kieler H
Article: BMC INFECTIOUS DISEASES. 2022;22(1):492
Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
Nakitanda AO; Karlsson P; Lofling L; Cesta CE; Odsbu I
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2021;100(11):2111-2118
Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia
Cesta CE; Chacon SS; Engeland A; Broe A; Damkier P; Furu K; Kieler H; Karlsson P
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2021;30(6):758-769
Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice: A post-authorization safety cohort study conducted in Europe and in the United States
Ehrenstein V; Huang K; Kahlert J; Bahmanyar S; Karlsson P; Lofling L; Nunes AP; Enger C; Bezemer ID; Kuiper JG; Hoti F; Juuti R; Korhonen P; Mo J; Schachterle SE; Wilner KD; Rorth M; Sorensen HT
Article: PLOS ONE. 2021;16(8):e0253944
Patterns of prescription dispensation and over-the-counter medication sales in Sweden during the COVID-19 pandemic
Karlsson P; Nakitanda AO; Lofling L; Cesta CE
Article: DRUG SAFETY. 2019;42(10):1167-1177
Study Design and Cohort Comparability in a Study of Major Cardiovascular Events in New Users of Prucalopride Versus Polyethylene Glycol 3350
Fortuny J; Gilsenan A; Cainzos-Achirica M; Cantero OF; Flynn RWV; Garcia-Rodriguez L; Kollhorst B; Karlsson P; Linner L; MacDonald TM; Plana E; Ruigomez A; Schink T; Ziemiecki R; Andrews EB
Article: DRUG SAFETY. 2019;42(10):1179-1190
Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study
Gilsenan A; Fortuny J; Cainzos-Achirica M; Cantero OF; Flynn RWV; Garcia-Rodriguez L; Harding A; Kollhorst B; Karlsson P; Linner L; MacDonald TM; Odsbu I; Plana E; Ruigomez A; Schink T; Ziemiecki R; Andrews EB
Article: KNEE. 2019;26(3):603-611
Income change after cruciate ligament injury - A population-based study
Marcano AI; Nordenvall R; Karlsson P; Gerdin M; Adami J; Palme M; Mattila VM; Bahmanyar S; Fellander-Tsai L
Article: JAMA PSYCHIATRY. 2018;75(2):167-175
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations A Cohort Study From the International Pregnancy Safety Study Consortium
Huybrechts KF; Broms G; Christensen LB; Einarsdottir K; Engeland A; Furu K; Gissler M; Hernandez-Diaz S; Karlsson P; Karlstad O; Kieler H; Lahesmaa-Korpinen A-M; Mogun H; Norgaard M; Reutfors J; Sorensen HT; Zoega H; Bateman BT
Article: PLOS ONE. 2017;12(8):e0182877
Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study
Lexomboon D; Karlsson P; Adolfsson J; Ekbom A; Naimi-Akbar A; Bahmanyar S; Montgomery S; Sandborgh-Englund G
Article: CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT. 2014;3(5):396-405
Population Pharmacokinetic and Pharmacodynamic Analysis of Plasma Aβ₄₀ and Aβ₄₂ Following Single Oral Doses of the BACE1 Inhibitor AZD3839 to Healthy Volunteers
Quartino A; Huledal G; Sparve E; Luttgen M; Bueters T; Karlsson P; Olsson T; Paraskos J; Maltby J; Claeson-Bohnstedt K; Lee C-M; Alexander R; Falting J; Paulsson B
Article: PSYCHOPHARMACOLOGY. 2014;231(6):1251-1265
A randomized, double-blind, placebo-controlled crossover study of α₄β₂* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Jucaite A; Ohd J; Potter AS; Jaeger J; Karlsson P; Hannesdottir K; Bostrom E; Newhouse PA; Paulsson B
Article: ACTA NEUROLOGICA SCANDINAVICA. 2014;129(2):114-122
Psychometric evaluation of ADAS-Cog and NTB for measuring drug response
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjoegren N; von Rosen T; Miller F
Article: JOURNAL OF BIOPHARMACEUTICAL STATISTICS. 2011;21(4):682-707
Confidence Regions for Bonferroni-Based Closed Tests Extended to More General Closed Tests
Guilbaud O; Karlsson P
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2006;41(3):264-273
Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects
Wilder-Smith CH; Jonzon B; Fornstedt-Wallin B; Hedman A; Karlsson P
Article: GUT. 2003;52(11):1537-1542
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans
Hawkey CJ; Jones JI; Atherton CT; Skelly MM; Bebb JR; Fagerholm U; Jonzon B; Karlsson P; T Bjarnason I
Article: INFLAMMOPHARMACOLOGY. 2003;11(4):437-444
The CINOD, AZD3582, exhibits an improved gastrointestinal safety profile compared with naproxen in healthy volunteers.
Jonzon B; Bjarnason I; Hawkey C; Jones J; Goddard A; Fagerholm U; Karlsson P
Visa fler

Alla övriga publikationer

Published conference paper: JOURNAL OF CLINICAL PSYCHIATRY. 2023;84(1):22m14430
Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study
Broms G; Hernandez-Diaz S; Huybrechts KF; Bateman BT; Kristiansen EB; Einarsdottir K; Engeland A; Furu K; Gissler M; Karlsson P; Klungsoyr K; Lahesmaa-Korpinen A-M; Mogun H; Norgaard M; Reutfors J; Sorensen HT; Zoega H; Kieler H
Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;32:586
Validation of diagnoses of hepatic disorders in users of systemic antifungal medication in Sweden
Giunta DH; Karlsson P; Younus M; Berglind IA; Reutfors J
Letter: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2020;324(9):895-897
Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway
Cesta CE; Engeland A; Karlsson P; Kieler H; Reutfors J; Furu K

Om mig

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI